45629-134-01 : NDC 2026 Code

45629-134-01 : Tivozanib ( Fotivda )

Additionally :

You can get information about “45629-134-01” NDC code in 45629-134-01 in HTML format

HTML | 45629-134-01 in TXT (Plain Text) format

TXT | 45629-134-01 in PDF (Portable Document Format)

PDF | 45629-134-01 in XML format

XML formats.

NDC Code : 45629-134-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "45629-134-01",
    "PackageDescription": "1 BOTTLE, PLASTIC in 1 BAG (45629-134-01)  / 21 CAPSULE in 1 BOTTLE, PLASTIC",
    "NDC11Code": "45629-0134-01",
    "ProductNDC": "45629-134",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Fotivda",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Tivozanib",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210310",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA212904",
    "LabelerName": "AVEO Pharmaceuticals, Inc.",
    "SubstanceName": "TIVOZANIB HYDROCHLORIDE",
    "StrengthNumber": "1.34",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20210310",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}